CDT EQUITY INC. Research and Development Expense
CDT EQUITY INC. (CDT) reported Research and Development Expense of $302.00 thousand for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-09-08
- CDT EQUITY INC. research and development expense for the quarter ending 2026-06-30 was $302.00K, a 83.76% decline year-over-year.
- CDT EQUITY INC. research and development expense for the quarter ending 2026-03-31 was $778.00K, a 15.07% decline year-over-year.
- CDT EQUITY INC. research and development expense for the quarter ending 2025-12-31 was $746.00K, a 465.15% increase year-over-year.
- CDT EQUITY INC. research and development expense for the quarter ending 2025-09-30 was $1.53M, a 50.47% decline year-over-year.
- CDT EQUITY INC. research and development expense for fiscal 2023 was $90.00K, a 143.24% increase from fiscal 2022.
- CDT EQUITY INC. research and development expense for fiscal 2022 was $37.00K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $302.00K S-1 · filed 2026-09-08 | $1.08M S-1 · filed 2026-09-08 | $1.83M derived: sum of 3 quarters · filed 2026-09-08 | $3.36M derived: sum of 4 quarters · filed 2026-09-08 | |
| 2026-03-31 | $778.00K 10-Q · filed 2026-07-15 | $1.52M derived: sum of 2 quarters · filed 2026-09-08 | $3.06M derived: sum of 3 quarters · filed 2026-09-08 | $4.92M derived: sum of 4 quarters · filed 2026-09-08 | |
| 2025-12-31 | $746.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-09-08 | $2.28M derived: sum of 2 quarters · filed 2026-09-08 | $4.14M derived: sum of 3 quarters · filed 2026-09-08 | $5.05M S-1 · filed 2026-09-08 | |
| 2025-09-30 | $1.53M 10-Q · filed 2025-11-13 | $3.39M derived: sum of 2 quarters · filed 2026-09-08 | $4.31M 10-Q · filed 2025-11-13 | $4.44M derived: sum of 4 quarters · filed 2026-09-08 | |
| 2025-06-30 | $1.86M S-1 · filed 2026-09-08 | $2.78M S-1 · filed 2026-09-08 | $2.91M derived: sum of 3 quarters · filed 2026-09-08 | $6.00M derived: sum of 4 quarters · filed 2026-09-08 | |
| 2025-03-31 | $916.00K 10-Q · filed 2026-07-15 | $1.31M 10-Q · filed 2025-05-15 | $1.05M derived: sum of 2 quarters · filed 2026-09-08 | $4.14M derived: sum of 3 quarters · filed 2026-09-08 | $4.17M derived: sum of 4 quarters · filed 2026-09-08 |
| 2024-12-31 | $132.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-09-08 | $3.23M derived: sum of 2 quarters · filed 2026-09-08 | $3.25M derived: sum of 3 quarters · filed 2026-09-08 | $3.38M S-1 · filed 2026-09-08 | |
| 2024-09-30 | $3.09M 10-Q · filed 2025-11-13 | $3.12M derived: sum of 2 quarters · filed 2025-11-13 | $3.25M 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $25.00K 10-Q · filed 2025-08-14 | $153.00K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $128.00K 10-Q/A · filed 2025-08-14 | ||||
| 2023-12-31 | $90.00K 10-K · filed 2025-03-28 | ||||
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | $37.00K derived: sum of 2 quarters · filed 2024-04-16 | $37.00K 10-K · filed 2024-04-16 | ||
| 2022-09-30 | $38.00K 10-Q/A · filed 2023-11-21 | $38.00K 10-Q/A · filed 2023-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |